Form
SCHEDULE 13G
Passive or exempt beneficial ownership filing.
Trails Edge Capital Partners, LP - 14 Apr 2026 SCHEDULE 13G Report for ImageneBio, Inc. Common Stock, $0.001 par value per share (IMA)
- Filing manager
- Trails Edge Capital Partners, LP
- Reporting owner
- Trails Edge Capital Partners, LP
- Beneficially owned shares
- 1,176,472 shares
- Large-stake signal
-
Ownership
9.9%Beneficial ownership of this reported class.
Shares
1,176,472 sharesShares beneficially owned as disclosed.
Event date
14 Apr 2026Date tied to the ownership event or amendment.
Accepted by SEC
21 Apr 2026EDGAR acceptance date.
How to read this large-stake filing
- Schedule 13D/G filings focus on beneficial ownership stakes, not a full portfolio.
- Compare this filing with the holder history and issuer page before treating the percentage as a current position.
- Use amendments to understand whether the disclosed stake increased, decreased, or changed reporting status.
- Class ownership
- 9.9%
- Symbol
- IMA
- Shares outstanding
- 11,883,556 shares
- SEC form
- SCHEDULE 13G
- Accepted by SEC
- 21 Apr 2026, 16:30:19 UTC
- Event date
- 14 Apr 2026
- Source filing
- View source filing
Ownership signal
CIK-linked ownership evidence from parsed SEC filings.
2 signals
Subject security
Names, identifiers, and filing context for this profile.
2 source fields
Source evidence
Original filing metadata and source links for verification.
4 source fields
Key filing fact
Trails Edge Capital Partners, LP disclosed 9.9% ownership in ImageneBio, Inc. Common Stock, $0.001 par value per share (IMA) on 14 Apr 2026.
Key facts
- Trails Edge Capital Partners, LP filed SCHEDULE 13G for ImageneBio, Inc. Common Stock, $0.001 par value per share (IMA).
- Disclosed ownership: 9.9%.
- Date of event: 14 Apr 2026.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 21 Apr 2026, 16:30.
Research use
- This page turns one Schedule 13D/G filing into a quick large-stake read before the raw reporting-person rows.
- Use the linked SEC filing as the source of truth for ownership percentages, shares, and reporting-party details.
Evidence
Backed by Schedule 13D/13G
View source filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Disclosed reporting parties (3)
Names, ownership percentages, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares owned | Sole voting power | Shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Trails Edge Capital Partners, LP | 9.9% | 1,176,472 | 1,176,472 | 0 | /s/ Trails Edge Capital Partners, LLC, GP of Trails Edge Capital Partners, LP /s/ Ortav Yehudai | Ortav Yehudai / Chief Investment Officer of Trails Edge Capital Partners, LLC | |
| Trails Edge Biotechnology Master Fund, LP | 9.9% | 1,176,472 | 1,176,472 | 0 | /s/ Trails Edge GP, LLC, GP of Trails Edge Biotechnology Fund GP, LP, GP of Trails Edge Biotechnology Master Fund, LP /s/ Ortav Yehudai | Ortav Yehudai / Chief Investment Officer of Trails Edge GP, LLC | |
| Ortav Yehudai | 9.9% | 1,176,472 | 1,176,472 | 0 | /s/ Ortav Yehudai | Ortav Yehudai / Individual |
CIK / CUSIP context first